VC-Backed Israeli Biopharma Co. Launches $55M IPO
Entera Bio Ltd., a clinical-stage Israeli biopharmaceutical company working on treatments for osteoporosis and a rare endocrine disorder, submitted plans Friday for a $55 million initial public offering, becoming the latest...To view the full article, register now.
Already a subscriber? Click here to view full article